The Lentiviral vector production core laboratory contract involves production of scalable clinical grade Lentiviral vectors, in accordance with Good Manufacturing Practices (GMP), as defined by the Food and Drug Administration (FDA), and applicable State and Federal regulations, for use by NHBLI funded investigators. It is expected that the contractor will produce an average of Twelve (12) vector batches per year for a minimum of three (3) batches for clinical studies or for safety and efficacy/dose/pharmacology/toxicology testing with large animal models.

Agency
National Institute of Health (NIH)
Type
Research and Development Contracts (N01)
Project #
268201200005I-0-26800003-1
Application #
8755770
Study Section
Project Start
2012-06-01
Project End
2017-05-31
Budget Start
Budget End
Support Year
Fiscal Year
2013
Total Cost
$61,521
Indirect Cost
Name
Indiana University-Purdue University at Indianapolis
Department
Type
DUNS #
603007902
City
Indianapolis
State
IN
Country
United States
Zip Code
46202